Latanoprost

drugbox
IUPAC_name = isopropyl ("Z")-7- [(1"R",2"R",3"R",5"S")-3,5-dihydroxy-2- [(3"R")3-hydroxy-5-phenylpentyl] -cyclopentyl] hept-5-enoate

---

---

CAS_number = 130209-82-4
ATC_prefix = S01
ATC_suffix = EE01
ATC_supplemental =
PubChem = 60798
DrugBank = APRD01065
C = 26 | H = 40 | O = 5
molecular_weight = 432.593 g/mol
smiles = O [C@@H] (CCc1ccccc1)CC [C@H] 1 [C@H] (O)C [C@H] (O) [C@@H] 1C/C=C/CCCC(=O)OC(C)C
bioavailability =
protein_bound =
metabolism =
elimination_half-life = 17 minutes
pregnancy_category =
legal_status =
routes_of_administration = Topical (eye drops)

Latanoprost (pronounced "la-TA-noe-prost") ophthalmic solution is a topical medication used for controlling the progression of glaucoma or ocular hypertension, by reducing intraocular pressure. It is a prostaglandin analogue that works by increasing the outflow of aqueous fluid from the eyes.

It is also known by the brand name of Xalatan manufactured by Pfizer.

ide effects

Possible side effects:
* May cause reddening of the eyes (hyperemia)
* May cause blurred vision;
* May cause eyelid redness;
* May permanently darken eyelashes;
* May cause eye discomfort;
* May eventually cause permanent darkening of the iris to brown (heterochromia);
* May cause a temporary burning sensation during use.
* May cause thickening of the eyelashes.
* Rarely, herpes simplex keratitis.

External links

* [http://www.xalatan.com/ Xalatan] (manufacturer's website)
*

]